Vestermark, L.W. et al. 2008. A phase II study of thalidomide in patients with brain metastases from malignant melanoma. Acta Oncologica. 47, 8 (Jan. 2008), 1526–1530. DOI:https://doi.org/10.1080/02841860801918521.